Chengdang Wang

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: July 01, 2026

Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: March 22, 2026

The Diagnostic Accuracy of Fecal Calprotectin for Colonoscopic Abnormalities in Patients With Chronic Diarrhea.

The Diagnostic Accuracy of Fecal Calprotectin for Colonoscopic Abnormalities in Patients With Chronic Diarrhea.

Journal: Journal of gastroenterology and hepatology

Published: February 20, 2026

Current status of 5-aminosalicylic acid in Crohn's disease treatment: a nationwide survey and analysis of perspectives and practice patterns among inflammatory bowel disease physicians.

Current status of 5-aminosalicylic acid in Crohn's disease treatment: a nationwide survey and analysis of perspectives and practice patterns among inflammatory bowel disease physicians.

Journal: Frontiers in gastroenterology (Lausanne, Switzerland)

Published: January 08, 2026

Integrated Machine Learning and Multi-Omics Identifies a Novel Molecular Signature for Improving the Prognosis of Hepatocellular Carcinoma.

Integrated Machine Learning and Multi-Omics Identifies a Novel Molecular Signature for Improving the Prognosis of Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: October 16, 2025

Gut microbiome and metabolome interactions in Crohn's disease: mechanistic insights into exclusive enteral nutrition-induced remission.

Gut microbiome and metabolome interactions in Crohn's disease: mechanistic insights into exclusive enteral nutrition-induced remission.

Journal: Frontiers in microbiology

Published: April 22, 2025

Hepatomegaly and ascites in a patient with UC.

Hepatomegaly and ascites in a patient with UC.

Journal: Gut

Published: August 10, 2024

Adropin regulates macrophage phenotype via PPARγ signalling: A preliminary study of adropin and Crohn's disease.

Adropin regulates macrophage phenotype via PPARγ signalling: A preliminary study of adropin and Crohn's disease.

Journal: Scandinavian journal of immunology

Published: March 27, 2024

Colonic multiple polypoidal protrusions: not familial adenomatous polyposis.

Colonic multiple polypoidal protrusions: not familial adenomatous polyposis.

Journal: Gut

Published: December 03, 2023

Diarrhea After Gastric Surgery: More Than Meets the Eye.

Diarrhea After Gastric Surgery: More Than Meets the Eye.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 27, 2023

Multiple Hepatic Masses in a Patient With Crohn's Disease.

Multiple Hepatic Masses in a Patient With Crohn's Disease.

Journal: Gastroenterology

Published: September 03, 2023

Identification of a Novel NLRP12 Frameshift Mutation (Val730Glyfs∗41) by Whole-Exome Sequencing in Patients with Crohn's Disease.

Identification of a Novel NLRP12 Frameshift Mutation (Val730Glyfs∗41) by Whole-Exome Sequencing in Patients with Crohn's Disease.

Journal: Human mutation

Published: July 27, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026